Cathie Wood: portfolio of ARK Investment Management
Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.
Source: 13F filing with the US Securities and Exchange Commission dated Oct 30, 2020. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q3 2020. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 16.9B USD
- Positions
- 223
- Share of the ten largest
- 43.2%
The ten largest positions Q3 2020
- Tesla, Inc. 8.7%▼ −3.7%
- Invitae Corp 7.1%▲ +16.5%
- Block, Inc. 5.6%▼ −3.4%
- Roku Inc 4.4%▲ +19.0%
- CRISPR Therapeutics AG 4.2%▲ +30.4%
- Zillow Group Inc 3.0%new
- 2U Inc 2.7%▲ +37.6%
- Teladoc Health Inc 2.6%▲ +1,416.5%
- LendingTree Inc 2.5%▲ +43.3%
- Proto Labs Inc 2.4%▲ +39.6%
Show all positions of this quarter
Choose a quarter (40 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
All positions Q3 2020
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| TSLA Tesla, Inc. | 8.7% | 3,430,778 | 1.5B USD | −3.7% reducedafter 5:1 stock split | Q4 2016 or earlier 16 quarters |
| XYZ Block, Inc. | 5.6% | 5,829,902 | 947.7M USD | −3.4% reduced | Q4 2016 or earlier 16 quarters |
| Seres Therapeutics Inc | 2.1% | 12,293,033 | 348.0M USD | −1.5% reduced | Q4 2016 or earlier 16 quarters |
| Pinterest Inc | 1.5% | 6,040,263 | 250.7M USD | −20.1% reduced | Q3 2019 5 quarters |
| Xilinx Inc | 1.1% | 1,848,208 | 192.7M USD | −11.5% reduced | Q4 2016 or earlier 16 quarters |
| 10X Genomics Inc | 0.2% | 231,097 | 28.8M USD | −31.3% reduced | Q2 2020 2 quarters |
| AAPL Apple Inc. | 0.2% | 229,924 | 26.6M USD | −44.5% reducedafter 4:1 stock split | Q1 2017 15 quarters |
| Guardant Health Inc | 0.2% | 234,021 | 26.2M USD | −49.0% reduced | Q2 2019 6 quarters |
| TER Teradyne | 0.1% | 307,698 | 24.5M USD | −82.5% reduced | Q4 2016 or earlier 16 quarters |
| Castle Biosciences Inc | 0.1% | 447,725 | 23.0M USD | −5.5% reduced | Q3 2019 5 quarters |
| ADSK Autodesk | < 0.1% | 55,188 | 12.7M USD | −83.8% reduced | Q4 2016 or earlier 16 quarters |
| WDAY Workday, Inc. | < 0.1% | 49,851 | 10.7M USD | −52.9% reduced | Q4 2017 12 quarters |
| PDD PDD Holdings | < 0.1% | 81,232 | 6.0M USD | −68.3% reduced | Q4 2018 8 quarters |
| Fiverr International Ltd | < 0.1% | 10,231 | 1.4M USD | −69.9% reduced | Q3 2019 5 quarters |
| Cellular Biomedicine Group Inc | < 0.1% | 71,010 | 1.3M USD | −88.2% reduced | Q1 2019 7 quarters |
| Redhill Biopharma Ltd | < 0.1% | 122,860 | 1.3M USD | −15.9% reduced | Q4 2017 12 quarters |
| Perion Network Ltd | < 0.1% | 152,230 | 1.1M USD | −29.6% reduced | Q4 2019 4 quarters |
| Fattal Holdings 1998 Ltd | < 0.1% | 18,692 | 1.1M USD | −8.9% reduced | Q3 2019 5 quarters |
| Danel Adir Yeoshua Ltd | < 0.1% | 8,522 | 988.0K USD | −40.3% reduced | Q4 2017 12 quarters |
| Nice Ltd | < 0.1% | 4,218 | 958.0K USD | −33.0% reduced | Q4 2017 12 quarters |
| Camtek Ltd/Israel | < 0.1% | 62,142 | 956.0K USD | −40.3% reduced | Q4 2017 12 quarters |
| Sapiens International Corp NV | < 0.1% | 30,300 | 927.0K USD | −38.6% reduced | Q3 2018 9 quarters |
| Bezeq The Israeli Telecommunic | < 0.1% | 796,730 | 926.0K USD | −47.4% reduced | Q4 2017 12 quarters |
| Ceragon Networks Ltd | < 0.1% | 366,555 | 913.0K USD | −29.3% reduced | Q4 2017 12 quarters |
| Nova Measuring Instruments Ltd | < 0.1% | 17,316 | 903.0K USD | −39.4% reduced | Q4 2017 12 quarters |
| Inmode Ltd | < 0.1% | 24,207 | 876.0K USD | −46.8% reduced | Q4 2019 4 quarters |
| Cellcom Israel Ltd | < 0.1% | 213,343 | 872.0K USD | −30.3% reduced | Q4 2017 12 quarters |
| Check Point Software Technolog | < 0.1% | 7,183 | 864.0K USD | −27.1% reduced | Q4 2017 12 quarters |
| Matrix IT Ltd | < 0.1% | 36,435 | 857.0K USD | −37.6% reduced | Q3 2019 5 quarters |
| Hilan Ltd | < 0.1% | 19,479 | 851.0K USD | −33.9% reduced | Q3 2019 5 quarters |
| RADA Electronic Industries Ltd | < 0.1% | 141,506 | 839.0K USD | −39.3% reduced | Q1 2020 3 quarters |
| Z Holdings Corp | < 0.1% | 62,911 | 838.0K USD | −5.4% reduced | Q4 2019 4 quarters |
| One Software Technologies Ltd | < 0.1% | 10,561 | 838.0K USD | −30.4% reduced | Q3 2019 5 quarters |
| AudioCodes Ltd | < 0.1% | 26,104 | 821.0K USD | −41.1% reduced | Q4 2017 12 quarters |
| CyberArk Software Ltd | < 0.1% | 7,732 | 800.0K USD | −33.7% reduced | Q4 2017 12 quarters |
| Radware Ltd | < 0.1% | 32,753 | 794.0K USD | −31.9% reduced | Q4 2017 12 quarters |
| Ituran Location and Control Lt | < 0.1% | 55,311 | 770.0K USD | −14.6% reduced | Q4 2017 12 quarters |
| Partner Communications Co Ltd | < 0.1% | 194,874 | 763.0K USD | −24.7% reduced | Q3 2019 5 quarters |
| Tower Semiconductor Ltd | < 0.1% | 40,501 | 738.0K USD | −29.2% reduced | Q4 2017 12 quarters |
| Allot Ltd | < 0.1% | 79,702 | 725.0K USD | −22.8% reduced | Q2 2019 6 quarters |
| Taro Pharmaceutical Industries | < 0.1% | 12,696 | 696.0K USD | −16.0% reduced | Q4 2017 12 quarters |
| Meituan Dianping | < 0.1% | 10,879 | 691.0K USD | −12.4% reduced | Q4 2019 4 quarters |
| Teva Pharmaceutical Industries | < 0.1% | 75,087 | 677.0K USD | −24.9% reduced | Q4 2017 12 quarters |
| UroGen Pharma Ltd | < 0.1% | 34,212 | 660.0K USD | −27.5% reduced | Q4 2017 12 quarters |
| ALGN Align Technology | < 0.1% | 1,872 | 613.0K USD | −12.2% reduced | Q4 2016 or earlier 16 quarters |
| Arconic Corp | < 0.1% | 24,415 | 465.0K USD | −21.7% reduced | Q2 2020 2 quarters |
| SHOP Shopify | < 0.1% | 188 | 192.0K USD | −64.3% reduced | Q2 2017 14 quarters |
| Eventbrite Inc | < 0.1% | 9,767 | 106.0K USD | −37.0% reduced | Q4 2018 8 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Consumer Discretionary 9.2%
- Technology 7.2%
- Financials 6.8%
- Health Care 3.9%
- Communication Services 1.9%
- Industrials 0.3%
- not in our coverage 70.6%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors